STUDY | DOSE | DURATION | BEFORE TREATMENT | AFTER TREATMENT | P VALUE |
Riahinejad(2015) | 850mg OD | 3 months | 9.11 ± 2.7 | 8.55 ± 2.49 | 0.035 |
Sahin (2007) | 2550mg OD | 6months | 12.8 ± 5.2 | 12.3 ± 5.6 | NS |
Vrbivoka (2002) | 500 mg OD initially and increased to 1000 mg OD | 1 week | 10.1 ± 2.6 | 13.4 ± 5.1 | <0.05 |
Haydardedeoglu (2009) | 850 mg BD | 6 months | 8.74 ± 1.9 | 10.97 ± 3.31 | 0.002 |
Yilmaz (2005) | 850 mg BD | 3 months | 13.52 ± 5.98 | 13.46 ± 6.01 | NS |
Kilicdag (2005) | 850 mg BD | 3 months | 8.93 ± 0.49 | 11.26 ± 0.86 | 0.002 |
Palombo (2010) | 1750 mg OD | 3 months | 11.1 ± 4.4 | 13.9 ± 3.8 | <0.05 |
Kilic S (2010) | 850 mg BD | 6 months | 8.99 ± 2.24 | 6.78 ± 2.15 | <0.001 |
|
| 6 months (obese) | 8.35 ± 2.22 | 6.64 ± 3.34 | 0.002 |
|
| 6 months (non-obese) |
|
|
|